ALLR vs BIIB: Which Stock is Better?

Side-by-side comparison of Allarity Therapeutics Inc and Biogen Inc in 2026

Comparison Updated:

ALLR

Allarity Therapeutics Inc

$1.05

BIIB

Biogen Inc

$189.94

Key Metrics Comparison

MetricALLRBIIBWinner
Market Cap$17.28M$27.88BBIIB
P/E Ratio0.2121.61ALLR
EPS (TTM)$5.75$8.79BIIB
Revenue Growth0.0%-0.1%BIIB
Gross Margin510.0%78.9%ALLR

Analyze ALLR

Full quant analysis

Analyze BIIB

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ALLR or BIIB a better investment?

Comparing ALLR and BIIB: Allarity Therapeutics Inc has a market cap of $17.28M while Biogen Inc has $27.88B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ALLR and BIIB?

ALLR (Allarity Therapeutics Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ALLR or BIIB?

Based on P/E ratios, ALLR trades at a lower multiple (0.2x vs 21.6x).

Which is growing faster: ALLR or BIIB?

ALLR has higher revenue growth at 0.0% vs -0.1% for BIIB.

Which company is more profitable: ALLR or BIIB?

Allarity Therapeutics Inc (ALLR) has higher gross margins at 510.0% compared to 78.9% for BIIB.

Which is the larger company: ALLR or BIIB?

Biogen Inc (BIIB) is larger with a market cap of $27.88B compared to $17.28M for ALLR.

Should I buy ALLR or BIIB in 2026?

Both ALLR and BIIB have investment merit. ALLR trades at $1.05 while BIIB trades at $189.94. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ALLR and BIIB stock?

Key differences: Market Cap ($17.28M vs $27.88B), P/E Ratio (0.2x vs 21.6x), Revenue Growth (0.0% vs -0.1%), Gross Margin (510.0% vs 78.9%).

Popular Stock Comparisons